Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease

2-(Benzylthio)-6-oxo-4-phenyl-1,6-dihydropyrimidine derivatives have been prepared and their inhibition activities against SARS-CoV 3CL protease were evaluated.